Diagnostics in Patients Suspect for Breast Cancer in The Netherlands

Author:

Voets Madelon M.ORCID,Groothuis-Oudshoorn Catharina G. M.,Veneklaas Liset H. J.,Manohar Srirang,Brinkhuis MariëlORCID,Veltman Jeroen,de Munck Linda,de Geus-Oei Lioe-FeeORCID,Broeders Mireille J. M.,Siesling Sabine

Abstract

The goal of this study was to describe the variation in hospital-based diagnostic care activities for patients with symptomatology suspect for breast cancer in The Netherlands. Two cohorts were included: the ‘benign’ cohort (30,334 women suspected of, but without breast cancer) and the ‘malignant’ cohort (2236 breast cancer patients). Hospital-based financial data was combined with tumor data (malignant cohort) from The Netherlands Cancer Registry. Patterns within diagnostic pathways were analyzed. Factors influencing the number of visits and number of diagnostic care activities until diagnosis were identified in the malignant cohort with multivariable Cox and Poisson regression models. Compared to patients with benign diagnosis, patients with malignant disease received their diagnosis less frequently in one day, after an equal average number of hospital visits and higher average number of diagnostic activities. Factors increasing the number of diagnostic care activities were the following: lower age and higher cM-and cN-stages. Factors increasing the number of days until (malignant) diagnosis were as follows: higher BIRADS-score, screen-detected and higher cN-and cT-stages. Hospital of diagnosis influenced both number of activities and days to diagnosis. The diagnostic care pathway of patients with malignant disease required more time and diagnostic activities than benign disease and depends on hospital, tumor and patient characteristics.

Funder

Horizon 2020 Research and Innovation Action

Publisher

MDPI AG

Reference24 articles.

1. World Cancer Report 2014;Steward,2014

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

3. Breast Cancer-Dutch Guideline, Version 2.0 www.oncoline.nl/breastcancer

4. Breast Cancer Screening Programme https://www.rivm.nl/en/Topics/B/Breast_cancer_screening_programme

5. New methods give better estimates of changes in diagnostic accuracy when prior information is provided

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3